OXIDATIVE STRESS AND KIDNEY OXYGEN USAGE
氧化应激和肾氧利用
基本信息
- 批准号:8067965
- 负责人:
- 金额:$ 38.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-05-01 至 2013-04-30
- 项目状态:已结题
- 来源:
- 关键词:ATP HydrolysisAcuteAcute Kidney FailureAdenosineAdultAngiotensin IIAntioxidantsBicarbonatesBlood PressureCell physiologyCellsChemicalsChronicCoupledCuprozinc Superoxide DismutaseCytokine SignalingDataDevelopmentDisabled PersonsDistalDoseDuct (organ) structureElectrolytesEnd stage renal failureEnergy MetabolismEnvironmentEnzymesEquilibriumEvaluationEventFailureFamilyFeedbackFibrosisFree EnergyFunctional disorderGene BankGenerationsGenesGeneticGenetic TranscriptionHomeostasisHypertensionHypoxiaHypoxia Inducible FactorIn VitroInflammationIntakeInterruptionIschemiaJuxtaglomerular ApparatusKidneyKidney DiseasesKnowledgeLeadLiquid substanceMacula densaManganese Superoxide DismutaseMeasurementMeasuresMessenger RNAMetabolismMicropunctureMitochondriaModelingMusNADPH OxidaseNephronsOutcomeOutputOxidantsOxidasesOxidative StressOxygenPathway interactionsPlasmaPrincipal InvestigatorProtein IsoformsProteinsRNA InterferenceRat-1RattusRenal Artery StenosisRenal Blood FlowRenal TissueRenal functionReninRenin-Angiotensin SystemResistanceRoleSclerosisSecondary HypertensionSeriesSignal TransductionSiteSodiumSourceStructure of ascending limb of Henle&aposs loopSuperoxide DismutaseSuperoxidesSusceptibility GeneSystemTestingThickTimeTubular formationVascular resistanceWild Type Mouseabsorptionarterioledesignempoweredextracellularhuman CYBA proteinin vivoinsightkidney cortexkidney vascular structuremonolayerpressurereceptorrenal ischemiaresearch studyresponsesolutetempoltransmission processuptakevasoconstriction
项目摘要
DESCRIPTION (provided by applicant): Renal oxidative stress is determined by the balance between the primary source of superoxide, NADPH oxidase (NOX) and intrarenal enzymes that scavenge superoxide, superoxide dismutases (SOD). Renal oxidative stress contributes to the development of systemic hypertension by alterations in renal function, including vasoconstriction, increased solute and electrolyte retention and tubular dysfunction. The reabsorption of sodium is the major energy requirement for the kidney and the efficient use of oxygen for Na+ transport is reduced during oxidative stress. We propose to test the effects of oxidative stress on oxygen usage in the kidney and to determine the mechanism(s) by which Na+ reabsorption requires greater oxygen. In a series of experiments measuring in vivo single nephron function in gene deleted mice and in vitro measurements of PT cell function we will identify specific sites of oxygen utilization dysfunction. In aim 1, we will test the hypothesis that the inefficient use of oxygen is dependent on the balance between NOX and SOD, by using single gene deleted mice. In aim 2 we will examine the mechanism of the inefficient use of oxygen, focusing on Na+ reabsorption in the proximal tubule (PT). In a series of both in vivo and in vitro experiments, we will evaluate the cellular integrity and function of the PT during acute and chronic oxidative stress. We will examine paracellular and transcellular function in PT cells. In aim 3 we will test the hypothesis that the increased blood pressure associated with angiotensin II-induced oxidative stress is dependent on increased generation of adenosine and enhancement of tubuloglomerular feedback, leading to decreased renal blood flow and increased renal vascular resistance. These studies should provide new and valuable information on the relationship between oxygen usage in the kidney and the pro-vasoconstriction events associated with oxidative stress and hypertension.
Project Narrative: Ischemia, the lack of efficient oxygen delivery is the most common cause of acute renal failure and renal artery stenosis causing renal ischemia is the second most common cause of secondary hypertension. These conditions are accompanied by severe oxidative stress within the kidneys. Therefore, knowledge of the interaction of oxidants and oxygen within the kidney will provide insight into the causes of these renal diseases.
描述(由申请人提供):肾脏氧化应激取决于清除超氧化物氧化酶(NADPH氧化酶(NOX)的主要来源之间的平衡,它们清除超氧化物,超氧化物歧化酶(SOD)。肾脏氧化应激有助于通过肾功能的改变(包括血管收缩,溶质增加和电解质保留和管状功能障碍)来发展全身性高血压。钠的重吸收是肾脏的主要能量需求,在氧化应激期间,有效利用氧气用于Na+转运。我们建议测试氧化应激对肾脏中氧使用的影响,并确定Na+重吸收需要更大氧的机制。在一系列测量基因删除小鼠体内单肾功能和PT细胞功能的体外测量中的实验中,我们将确定氧气利用功能障碍的特定位点。在AIM 1中,我们将通过使用单个基因删除的小鼠来检验以下假设:氧气使用效率低下取决于NOX和SOD之间的平衡。在AIM 2中,我们将检查氧气效率低下的机制,重点是近端小管(PT)中的Na+重吸收。在一系列体内和体外实验中,我们将在急性和慢性氧化应激期间评估PT的细胞完整性和功能。我们将检查PT细胞中细胞细胞和跨细胞功能。在AIM 3中,我们将检验以下假设:与血管紧张素II诱导的氧化应激相关的血压升高取决于腺苷的产生增加和肾小管层状反馈的增强,从而导致肾血流降低和肾血管耐药性增加。这些研究应提供有关肾脏中氧使用与与氧化应激和高血压相关的促骨收缩事件之间关系的新信息。
项目叙述:缺血,缺乏有效的氧气递送是急性肾衰竭和导致肾脏缺血的肾动脉狭窄的最常见原因,是次要高血压的第二大最常见原因。这些条件伴随着肾脏内的严重氧化应激。因此,肾脏中氧化剂和氧相互作用的知识将为这些肾脏疾病的原因提供洞察力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William J Welch其他文献
William J Welch的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William J Welch', 18)}}的其他基金
相似国自然基金
阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
- 批准号:82302281
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
- 批准号:22304039
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
RNA甲基转移酶NSUN2介导SCD1 mRNA m5C修饰调控急性髓系白血病细胞铁死亡的机制研究
- 批准号:82300173
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于IRF5/MYD88信号通路调控巨噬细胞M1极化探讨针刀刺营治疗急性扁桃体炎的机制研究
- 批准号:82360957
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:地区科学基金项目
相似海外基金
ENTPD1: A Candidate Susceptibility Gene for Renovascular Disease
ENTPD1:肾血管疾病的候选易感基因
- 批准号:
7993859 - 财政年份:2009
- 资助金额:
$ 38.38万 - 项目类别: